Related Experiment Video
Updated: Mar 2, 2026

Automated Imaging and Analysis for the Quantification of Fluorescently Labeled Macropinosomes
Published on: August 24, 2021
Halofuginone dually regulates autophagic flux through nutrient-sensing pathways in colorectal cancer
Guo-Qing Chen1,2, Rui-Hong Gong1, Da-Jian Yang2
1Laboratory of Brain and Gut Research, Center for Clinical Research on Chinese Medicine, School of Chinese Medicine, Hong Kong Baptist University, Hong Kong SAR, China.
Abstract:
Autophagy has a key role in metabolism and impacts on tumorigenesis. Our previous study found that halofuginone (HF) exerts anticancer activity in colorectal cancer (CRC) by downregulating Akt/mTORC1 (mechanistic target of rapamycin complex 1) signaling pathway. But whether and how HF regulates autophagy and metabolism to inhibit cancer growth remains an open question. Here, we unveil that HF activates ULK1 by downregulation of its phosphorylation site at Ser757 through Akt/mTORC1 signaling pathway, resulting in induction of autophagic flux under nutrient-rich condition. On the other hand, HF inactivates ULK1 by downregulation of its phosphorylation sites at Ser317 and Ser777 through LKB1/AMPK signaling pathway, resulting in autophagic inhibition under nutrient-poor condition. Furthermore, Atg7-dependent autophagosome formation is also induced under nutrient-rich condition or blocked in nutrient-poor environment, respectively, upon HF treatment. More interestingly, we also found that HF inhibits glycolysis under nutrient-rich condition, whereas inhibits gluconeogenesis under nutrient-poor condition in an Atg7-dependent manner, suggesting that autophagy has a pivotal role of glucose metabolism upon HF treatment. Subsequent studies showed that HF treatment retarded tumor growth in xenograft mice fed with either standard chow diet or caloric restriction through dual regulation of autophagy in vivo. Together, HF has a dual role in autophagic modulation depending on nutritional conditions for anti-CRC.
Insights
Halofuginone (HF) shows dual regulation of autophagy in colorectal cancer (CRC) by modulating ULK1 activity based on nutrient availability, impacting tumor growth.
Area of Science:
- Cellular Biology
- Cancer Research
- Metabolism
Background:
- Autophagy plays a crucial role in cellular metabolism and tumorigenesis.
- Halofuginone (HF) previously demonstrated anticancer effects in colorectal cancer (CRC) by inhibiting the Akt/mTORC1 pathway.
- The precise mechanisms by which HF influences autophagy and metabolism in cancer remain unclear.
Purpose of the Study:
- To elucidate how halofuginone (HF) regulates autophagy and metabolism in colorectal cancer (CRC) under varying nutritional conditions.
- To investigate the role of ULK1, Akt/mTORC1, and LKB1/AMPK signaling pathways in HF-mediated autophagy modulation.
- To determine the impact of HF on glucose metabolism and tumor growth in vivo.
Main Methods:
- Investigated HF effects on ULK1 phosphorylation at specific sites (Ser757, Ser317, Ser777) in relation to Akt/mTORC1 and LKB1/AMPK signaling.
- Assessed Atg7-dependent autophagosome formation under nutrient-rich and nutrient-poor conditions.
- Analyzed HF's impact on glycolysis and gluconeogenesis.
- Evaluated HF's anti-tumor efficacy in xenograft mouse models with different dietary conditions.
Main Results:
- HF activates ULK1 via Akt/mTORC1, inducing autophagy under nutrient-rich conditions.
- HF inactivates ULK1 via LKB1/AMPK, inhibiting autophagy under nutrient-poor conditions.
- HF modulates glucose metabolism (inhibiting glycolysis or gluconeogenesis) in an Atg7-dependent manner.
- HF treatment suppressed tumor growth in vivo, irrespective of diet, due to dual autophagy regulation.
Conclusions:
- Halofuginone exhibits a context-dependent dual role in autophagy modulation in colorectal cancer.
- HF's regulation of autophagy is intricately linked to nutritional status and impacts glucose metabolism.
- These findings highlight HF as a potential therapeutic agent for CRC, leveraging its ability to dual-regulate autophagy for anti-tumor effects.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...

